体素内不相干运动量化指标联合时间-信号强度曲线在非小细胞肺癌氩氦刀治疗后残留病灶早期诊断中的意义研究
纳入100例接受氩氦刀治疗的非小细胞肺癌患者,按穿刺活检和随访分为残留组21例与无残留组79例。比较治疗后7天和1个月时IVIM量化指标及TIC类型,IVIM联合TIC诊断残留的灵敏度和特异度在7天为97.5%和85.7%,1个月为97.5%和90.5%,效果优于常规MRI和DWI。
要点
- 残留组与无残留组治疗后7天和1个月ADC、sADC、ffADC差异均有统计学意义(均P<0.05)。
- 治疗后7天sADC和ffADC的AUC分别为0.861和0.895,灵敏度81.0%和90.5%,特异度77.2%和73.4%。
- IVIM量化指标联合TIC类型诊断残留的效能优于常规MRI和DWI。
核心结论
- IVIM量化指标结合TIC类型可用于NSCLC氩氦刀治疗后残留病灶的早期精确诊断,效果优于常规MRI和DWI。
研究设计与样本
- 收集100例行氩氦刀治疗的NSCLC患者,根据穿刺活检和随访结果分为残留组21例和无残留组79例。
- 比较两组治疗后7天和1个月时的IVIM量化指标ADC、sADC、fADC、ffADC及TIC类型差异,采用ROC曲线评估诊断效能并确定最佳界值。
- 评估IVIM量化指标联合TIC类型对病灶残留早期诊断的效力,并与磁共振常规扫描和DWI序列进行比较。
主要发现
- 治疗后7天和1个月时,残留组与无残留组间ADC、sADC和ffADC差异有统计学意义(均P<0.05),其中sADC和ffADC诊断效果较好。
- 治疗后7天sADC和ffADC的AUC分别为0.861和0.895,灵敏度分别为81.0%和90.5%,特异度分别为77.2%和73.4%。
- 治疗后1个月sADC和ffADC的AUC分别为0.836和0.883,灵敏度分别为100.0%和76.2%,特异度分别为58.2%和89.9%。
- 以Ⅱ+Ⅲ型TIC为诊断标准时,治疗后7天灵敏度和特异度分别为80.9%和58.2%,治疗后1个月分别为85.7%和62.0%。
- 治疗后7天IVIM联合TIC的灵敏度和特异度分别为97.5%和85.7%,治疗后1个月分别为97.5%和90.5%,诊断性能优于常规MRI和DWI。
关键数值与推荐
- 治疗后7天sADC的AUC为0.861,灵敏度81.0%,特异度77.2%;ffADC的AUC为0.895,灵敏度90.5%,特异度73.4%。
- 治疗后1个月sADC的AUC为0.836,灵敏度100.0%,特异度58.2%;ffADC的AUC为0.883,灵敏度76.2%,特异度89.9%。
- 以Ⅱ+Ⅲ型TIC为诊断标准,治疗后7天灵敏度80.9%、特异度58.2%,治疗后1个月灵敏度85.7%、特异度62.0%。
- IVIM联合TIC治疗后7天灵敏度97.5%、特异度85.7%,治疗后1个月灵敏度97.5%、特异度90.5%。
临床怎么用
- 原文结论认为IVIM量化指标结合TIC类型可用于NSCLC氩氦刀治疗后残留病灶的早期精确诊断,效果优于常规MRI和DWI。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To study the application of intravoxel incoherent motion (IVIM) quantitative index combined with time-signal intensity curve (TIC) of dynamic contrast enhanced 3.0T magnetic resonance in the early precise diagnosis of residual lesions in non-small cell lung cancer (NSCLC) after argon-helium cryosurgery. Methods: One hundred NSCLC patients who underwent argon-helium cryosurgery were collected and divided into the residual group (21 cases) and non-residual group (79 cases) according to the result of needle biopsy and follow-up. The apparent diffusion coefficient (ADC), slow apparent diffusion coefficient (sADC), fast apparent diffusion coefficient (fADC), fraction of fast apparent diffusion coefficient (ffADC) and TIC type of IVIM quantitative index between the two groups were compared at 7 days and 1 month after argon-helium cryosurgery, respectively. The diagnosis performance of each quantitative index was analyzed by receiver operating characteristic (ROC) curve and the best cut-off value was computed. The specificity and sensitivity of TIC types were calculated as diagnostic criteria. The diagnosis performance of IVIM quantitative index combined with TIC type was evaluated and compared with the conventional MRI and DWI. Results: The differences of ADC, sADC and ffADC at 7 days and 1 month after argon-helium cryosurgery between the residual group and non-residual group were statistically significant (all P<0.05), in which the diagnosis performance of sADC and ffADC were better. The AUC of sADC and ffADC at 7 days after argon-helium cryosurgery were 0.861 and 0.895, the sensitivity were 81.0% and 90.5%, and the specificity were 77.2% and 73.4%, respectively. The AUC of sADC and ffADC at 1 month after argon-helium cryosurgery were 0.836 and 0.883, the sensitivity were 100.0% and 76.2%, and the specificity were 58.2% and 89.9%, respectively. The diagnosis performance of TIC type Ⅱ&Ⅲ was best. The sensitivity and specificity were 80.9% and 58.2% at 7 days after treatment, 85.7% and 62.0% at 1 month after treatment, respectively. At 7 days after treatment, the sensitivity and specificity of IVIM combined with TIC were 97.5% and 85.7%, while at 1 month after treatment, the sensitivity and specificity of IVIM combined with TIC were 97.5% and 90.5%, respectively. The diagnosis performance of IVIM quantitative index combined with TIC type was better than conventional MRI and DWI. Conclusion: The combination of IVIM quantitative index and TIC type can be used in the early diagnosis of residual lesions after argon-helium cryosurgery for NSCLC, whose effect is better than conventional MRI and DWI. 目的: 探讨3.0T磁共振体素内不相干性运动(IVIM)量化指标联合动态增强扫描的时间-信号强度曲线(TIC)在非小细胞肺癌(NSCLC)氩氦刀治疗后病灶残留早期诊断中的应用价值。 方法: 收集100例行氩氦刀治疗的NSCLC患者,根据穿刺活检和随访结果将患者分为残留组(21例)和无残留组(79例)。比较两组患者治疗后7 d和1个月时的IVIM量化指标综合表观扩散系数(ADC)、慢速表观扩散系数(sADC)、快速表观扩散系数(fADC)、快速扩散所占容积分数(ffADC)及TIC类型的差异,采用受试者工作特征(ROC)曲线分析评估量化指标的诊断效能,并确定最佳界值。计算TIC类型作为诊断标准时的灵敏度和特异度。评估IVIM量化指标联合TIC类型对病灶残留早期诊断的效力,并与磁共振常规扫描和扩散加权成像(DWI)序列进行比较。 结果: 治疗后7 d和1个月时,残留组和无残留组间ADC、sADC和ffADC差异有统计学意义(均P<0.05),其中sADC和ffADC诊断氩氦刀治疗后病灶残留的效果较好。治疗后7 d时,sADC和ffADC诊断氩氦刀治疗后病灶残留的AUC分别为0.861和0.895,灵敏度分别为81.0%和90.5%,特异度分别为77.2%和73.4%。治疗后1个月时,AUC分别为0.836和0.883,灵敏度分别为100.0%和76.2%,特异度分别为58.2%和89.9%。以Ⅱ+Ⅲ型TIC为局部病灶残留诊断标准的诊断效果最好,治疗后7 d时的灵敏度和特异度分别为80.9%和58.2%,治疗后1个月时的灵敏度和特异度分别为85.7%和62.0%。治疗后7 d时,IVIM指标联合TIC类型的灵敏度和特异度分别为97.5%和85.7%;治疗后1个月时,IVIM指标联合TIC类型的灵敏度和特异度分别为97.5%和90.5%。IVIM量化指标联合TIC类型的诊断性能优于磁共振常规扫描和DWI。 结论: 应用IVIM量化指标结合TIC类型可以对NSCLC氩氦刀治疗后的病灶残留进行早期精确诊断,效果优于磁共振常规扫描和DWI。.
引用
- Zong DW, Guo CY, Li HL, et al. [Study on the significance of intravoxel incoherent motion quantitative index combined with time-signal intensity curve in the early diagnosis of residual lesions in non-small cell lung cancer after argon-helium cryosurgery]. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 30481938. doi:10.3760/cma.j.issn.0253-3766.2018.11.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。